Related Experiment Video For Breast-conserving surgery
Updated: Jan 18, 2026

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
Published on: September 22, 2013
Three-dimensional histological electrophoresis with fluorescence labeling for detection of malignant tissue contours
Mengxin Li1, Feiran Zhang2, Jiawei Gao2
1Department of Breast Surgery, General Surgery Center, First Hospital of Jilin University, Changchun, PR China; Joint Laboratory of Opto-Functional Theranostics in Medicine and Chemistry, The First Hospital of Jilin University, Changchun, 130021, PR China.
Background:
Breast-conserving surgery (BCS) is the primary surgical approach for patients with breast cancer. The accurate determination of surgical margins during BCS is critical for patient prognosis; however, time constraints and limitations in current pathological techniques often prevent pathologists from performing this assessment intraoperatively. The inability to reliably assess margins during surgery can lead to incomplete tumor removal and the need for additional surgeries. The challenge remains to develop a real-time, reliable method for margin assessment during surgery to improve patient outcomes and reduce healthcare costs.
Results:
We developed a three-dimensional (3D) histological electrophoresis platform that could directly and accurately determine the margin status and distances in six directions for BCS samples during surgery. The platform incorporated a microporous array mold to hold frozen tissue slices, electrophoresis for isolating IR780-labeled proteins, gel imaging using ImageJ and AzureSpot, and a diagnostic algorithm developed using MATLAB. The method can rapidly label tumor-associated proteins within tissue sections by employing a tumor-selective dye (IR-780) conjugated with albumin and RAC-α serine/threonine-protein kinase (AKT1), both of which are highly expressed in breast cancer tissues. It autonomously distinguishes malignant regions from benign ones based on protein signaling, thereby reducing the reliance on visual diagnosis and accelerating intraoperative decision-making. The device was tested on various types of human breast tissues from 36 patients to demonstrate the accuracy and efficiency of the device for use in BCS therapy.
Significance:
The platform leverages post-electrophoresis signal differences across various tissue types to predict the contours of malignant tissues. By generating margin distances in multiple directions, it addresses the gap in surgical margin calculation during clinical procedures. This saves time and reduces the costs associated with traditional pathological examinations, enhancing diagnostic detection efficiency. As a result, it improves the accuracy of tumor margin assessment, facilitating better surgical outcomes and treatment planning.
More Related Videos
07:16Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
Published on: April 25, 2025
13:01Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022